scholarly journals Airway Mast Cells on a Type-2 Inflammatory Background Confer a More Clinically Severe Asthma Phenotype Than Isolated Type-2 Inflammation

2017 ◽  
Vol 139 (2) ◽  
pp. AB180
Author(s):  
Merritt L. Fajt ◽  
John B. Trudeau ◽  
Fernando Holguin ◽  
Sally E. Wenzel
Keyword(s):  
Mast Cells ◽  
Severe Asthma ◽  
Asthma Phenotype ◽  
Type 2 Inflammation

scholarly journals COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.

2021 ◽  
Vol 147 (2) ◽  
pp. AB40
Author(s):  
Alicia Domínguez Estirado ◽  
Gabriela Zambrano Ibarra ◽  
Filip Skrabski ◽  
Francisco Javier De Castro Martínez ◽  
Julia De Pedro ◽  
...  
Keyword(s):  
Severe Asthma ◽  
Level Hospital ◽  
Type 2 Inflammation

P068 DUPILUMAB REDUCES BIOMARKERS OF TYPE 2 INFLAMMATION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA

2021 ◽  
Vol 127 (5) ◽  
pp. S33
Author(s):  
L. Bacharier ◽  
J. Maspero ◽  
C. Katelaris ◽  
A. Fiocchi ◽  
D. Liu ◽  
...  
Keyword(s):  
Severe Asthma ◽  
Type 2 Inflammation

Biologics targeting type 2 inflammation in severe asthma

Severe Asthma ◽  
2019 ◽  
pp. 285-303 ◽  
Author(s):  
Ian D. Pavord ◽  
Rahul Shrimanker ◽  
Nicola A. Hanania
Keyword(s):  
Severe Asthma ◽  
Type 2 Inflammation

Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma

2014 ◽  
Vol 1 (1) ◽  
pp. 2-10
Author(s):  
Lawren Wu ◽  
Joseph Arron ◽  
Jeffrey Harris ◽  
John Matthews ◽  
Karin Rosen
Keyword(s):  
Severe Asthma ◽  
Therapeutic Targeting ◽  
Type 2 Inflammation
Sign in / Sign up

Export Citation Format

Share Document